Cargando…
Macrolipasemia secondary to colon cancer chemotherapy: a case report
We reported macrolipasemia in a colon cancer patient during the chemotherapy period without any evidence of pancreatitis. A 52-year-old man formerly treated for papillary thyroid carcinoma had elevated a carcinoembryonic antigen (CEA) concentration in the latest control and was diagnosed with colon...
Autores principales: | Saracoglu, Hatice, Baskol, Gulden, Baskol, Mevlut |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495620/ https://www.ncbi.nlm.nih.gov/pubmed/34658648 http://dx.doi.org/10.11613/BM.2021.030801 |
Ejemplares similares
-
Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis
por: Bayram, Fahri, et al.
Publicado: (2013) -
Increased Chromosomal and Oxidative DNA Damage in Patients with Multinodular Goiter and Their Association with Cancer
por: Donmez-Altuntas, Hamiyet, et al.
Publicado: (2017) -
Successful Treatment of Gastric Relapse in Multiple Myeloma with Bortezomib after Autologous Hematopoietic Stem Cell Transplantation (autoHSCT)
por: Sivgin, Serdar, et al.
Publicado: (2013) -
Role of osteocalcin, tumor necrosis factor-alpha and adiponectin in polycystic ovary syndrome patients with insulin resistance
por: Erkan, Gönül, et al.
Publicado: (2017) -
A molecular analysis of familial Mediterranean fever disease in a cohort of Turkish patients
por: Dundar, Munis, et al.
Publicado: (2012)